Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADXS11-001 neoadjuvant vaccination in HPV+ oropharyngeal cancer
NCT02002182Phase 2Completed
- Start
- Dec 2013
- Primary completion
- Jul 2018
- Modality
- Gene Editing, Gene Silencing, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of axalimogene filolisbac in oropharyngeal squamous cell carcinoma (OPSCC). Started Dec 2013; status: completed.
02
Drugs
axalimogene filolisbac
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT02002182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002182.